Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 3Carcinoma, Hepatocellular 3Thyroid Nodule 2Lung Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Osteosarcoma 1Leiomyoma 1Hyperthyroidism 1Fibrosis 1Esophageal Squamous Cell Neoplasia (ESCN) 1Carcinoma, Renal Cell 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

telapristone acetate 9vilaprisan 6ulipristal acetate 4Sugars 2Mifepristone 2Bupivacaine 2ulipristal 1ferrous sulfate 1epigallocatechin gallate 1Vitamin B 6 1Uterine Myomectomy 1Tranexamic Acid 1Tea 1Standard of Care 1Radiofrequency Ablation 1Pregabalin 1Morphine 1Misoprostol 1Lidocaine 1Leuprolide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leiomyoma × Radiofrequency Ablation × Clear all
NCT00584207 2009-04-23

Radiofrequency Ablation of Uterine Fibroids

University of California, Davis

Phase EARLY_PHASE1 Terminated
15 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡